Latest dacarbazine Stories

Melanoma Treatments Receive FDA Approval
2013-05-30 12:43:33

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) has approved two new medicines used to treat the most dangerous form of skin cancer, as well as a genetic test developed alongside those drugs. The two new medications, both of which are manufactured by GlaxoSmithKline (GSK), are dabrafenib (which will be marketed as Tafinlar) and trametinib (which will be sold under the name Mekinist). They will be used to treat patients with advanced...

Two Experimental Drugs Showing Promise In Melanoma Fight
2012-06-04 13:41:38

Researchers presented findings on Monday at the American Society of Clinical Oncology meeting in Chicago of two experimental treatments that treat advanced melanoma. The two experimental treatments, known as Dabrafenib and Tramentinib, are being developed by GlaxoSmithKline and are showing promising results to combat the deadly skin cancer. The researchers said that the trial on Tramentinib included 322 people, 214 of which took the experimental drug while the rest did chemotherapy....

2011-08-17 09:34:00

Decision Opens New Doors to Long-Awaited Combination Trials WASHINGTON, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Melanoma patients who have long faced a bleak treatment landscape are gaining a new approach for treating the deadliest form of skin cancer. The Food and Drug Administration today announced the approval of Zelboraf, known as vemurafenib or PLX4032 during testing, well ahead of the approval deadline. Zelboraf is the first drug to treat advanced melanoma by targeting a specific...

2011-08-17 08:59:00

PARSIPPANY, N.J., Aug. 17, 2011 /PRNewswire/ -- With the US Food and Drug Administration (FDA) approval today of Zelboraf(TM) (vemurafenib), a first-in-class personalized treatment for patients with unresectable (inoperable) or metastatic melanoma with a BRAF V600E mutation as detected by an FDA-approved test, Daiichi Sankyo prepares to enter the US cancer market with its first oral, targeted anti-cancer therapy. "The Zelboraf approval is not only a significant milestone for these...

2011-08-17 07:47:00

Second melanoma drug approved this year that improves overall survival SILVER SPRING, Md., Aug. 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Zelboraf is specifically indicated for the treatment of patients with...

2011-06-06 12:35:00

A new study found that people with advanced melanoma who were treated with Bristol-Myers Squibb Co.'s Yervoy plus chemotherapy lived an average of two months longer than people who got chemotherapy alone. The study is the first to show that combining chemotherapy and an immune-system treatment is safe and effective for patients with advanced melanoma. It is also the second major trial to show Yervoy (ipilimumab), a new type of immunotherapy drug, can improve survival in patients with the...

2011-05-11 05:00:00

PARSIPPANY, N.J. and TOKYO, May 11, 2011 /PRNewswire/ -- Daiichi Sankyo announced that applications have been submitted for market approval for vemurafenib (PLX4032/RG7204) for the treatment of metastatic melanoma to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Additionally, a pre-marketing application for approval for a companion diagnostic test has been submitted in the U.S.; the test also will be registered in Europe. Vemurafenib is an oral,...

2011-03-25 12:59:00

-FDA decision on immunotherapy means first new treatment option in more than a decade becoming available- WASHINGTON, March 25, 2011 /PRNewswire-USNewswire/ -- Thirteen years of waiting is now over for melanoma patients. That's how long it's been since the last therapy became available to treat the most lethal form of skin cancer - melanoma. The FDA today announced approval of Yervoy, an immunotherapy treatment for advanced melanoma. The drug will be used to treat melanoma patients...

Word of the Day
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.